Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Arcus Biosciences, Inc. (RCUS) had Days Sales in Receivables of 30.00 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$33.00M |
|
$-106.00M |
|
-- |
|
$33.00M |
|
$147.00M |
|
$-114.00M |
|
$8.00M |
|
$-106.00M |
|
$-106.00M |
|
$-106.00M |
|
$-106.00M |
|
$-106.00M |
|
$-106.00M |
|
$-114.00M |
|
$-114.00M |
|
107.40M |
|
107.40M |
|
$-0.88 |
|
$-0.88 |
|
| Balance Sheet Financials | |
$1.01B |
|
$40.00M |
|
$132.00M |
|
$1.14B |
|
$231.00M |
|
$99.00M |
|
$277.00M |
|
$508.00M |
|
$631.00M |
|
$631.00M |
|
$631.00M |
|
125.30M |
|
| Cash Flow Statement Financials | |
$-482.00M |
|
$66.00M |
|
$488.00M |
|
$153.00M |
|
$225.00M |
|
$72.00M |
|
$60.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.36 |
|
-- |
|
-- |
|
0.14 |
|
0.16 |
|
100.00% |
|
-345.45% |
|
-345.45% |
|
-- |
|
-321.21% |
|
-321.21% |
|
$-484.00M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
3.00 |
|
|
Days Sales in Receivables |
30.00 |
-16.80% |
|
-16.80% |
|
-9.31% |
|
-14.52% |
|
$5.04 |
|
$-4.51 |
|
$-4.49 |
|